(Q35647641)

English

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.

scientific article published on June 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

based on heuristic

inferred from title

Jakob R. Passweg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nicolaas Schaap

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sebastian Giebel

19

object named as

S Giebel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

5

object named as

G Socié

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

M Labopin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

J Cornelissen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A Huynh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

R Tabrizi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

D Wu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

C Craddock

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

J Kuball

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

P Chevallier

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

J Y Cahn

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

D Blaise

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A Ghavamzadeh

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

K Bilger

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

F Ciceri

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

C Schmid

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A Nagler

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

M Mohty

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Acute Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT)

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

1 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1063-1068

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Therapeutic advances in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Acute myeloid leukemia: 2013 update on risk-stratification and management

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Acute myeloid leukaemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

The myth of the second remission of acute leukemia in the adult

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

A novel hierarchical prognostic model of AML solely based on molecular mutations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.121

21 January 2018

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26030052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2015.121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26030052%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35647641&oldid=2197575629"